Search Results - hpv

4 Results

Sort By:

A Sensitive, High Throughput Pseudovirus-Based Papillomavirus Neutralization Assay for HPV 16 and HPV 18

Abstract: Human Papilloma Viruses (HPV) is a very common virus; nearly 80 million people—about one in four—are currently infected in the United States. HPV is a group of more than 150 related viruses. Each HPV virus in this large group is given a number which is called its HPV type. HPV is named for the warts (papillomas) some that HPV types can cause....

Published: 4/8/2024 | Inventor(s): John Schiller, Christopher Buck, Diana Pastrana, Douglas Lowy, Richard Roden

Keywords(s): assay, bovine papillomavirus, HPV, Human Papilloma Viruses

Category(s): TherapeuticArea > Infectious Disease, Application > Research Materials, TherapeuticArea > Oncology, Collaboration Sought > Licensing

Agonist Epitopes for the Development of a Human Papillomavirus (HPV) Therapeutic Vaccine

Abstract: Human papillomavirus (HPV) has been associated with the cause of several cancer types, including cervical, anal, and head and neck cancers. There has been great success in preventing HPV infections with the development of prophylactic HPV vaccines, Gardasil and Cervarix. However, these vaccines have only been shown to prevent HPV infection...

Published: 4/8/2024 | Inventor(s): Jeffrey Schlom, Kwong-Yok Tsang

Keywords(s): Agonist Epitope, CTL, Cytotoxic T Lymphocytes, HPV, Human Papillomavirus, Schlom, Therapeutic Vaccine

Category(s): TherapeuticArea > Oncology, Collaboration Sought > Collaboration, Collaboration Sought > Licensing, Application > Therapeutics

T-cell Receptor Targeting Human Papillomavirus-16 E7 Oncoprotein

Abstract: Human papillomavirus (HPV) is a group of human viruses known to cause various malignancies. Of the group, HPV-16 is the most prevalent strain – an estimated 90% of adults have been exposed. HPV-16 is also the strain most commonly associated with malignancy, causing the vast majority of cervical, anal, vaginal, vulvar, and penile cancers. Currently,...

Published: 4/8/2024 | Inventor(s): Christian Hinrichs, Steven Rosenberg

Keywords(s): act, adoptive cell therapy, Cervical cancer, E7, HLA-A*02, HPV, Human Papillomavirus, Major Histocompatibility Complex, MALIGNANCY, MHC, ONCOPROTEIN, Rosenberg, T Cell Receptor, TCR

Category(s): TherapeuticArea > Oncology, Collaboration Sought > Licensing, Application > Therapeutics, Collaboration Sought > Collaboration, TherapeuticArea > Infectious Disease

T-cell Receptor Targeting Human Papillomavirus-16 E6 Oncoprotein

Published: 4/8/2024 | Inventor(s): Christian Hinrichs, Steven Rosenberg

Keywords(s): act, adoptive cell therapy, Cervical cancer, E6, HLA-A*02, HPV, Human Papillomavirus, Major Histocompatibility Complex, MALIGNANCY, MHC, ONCOPROTEIN, Rosenberg, T Cell Receptor, TCR

Category(s): TherapeuticArea > Oncology, TherapeuticArea > Infectious Disease, Collaboration Sought > Licensing, Collaboration Sought > Collaboration, Application > Therapeutics